1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Oligospermia: new trials by email Literature Review of Oligospermia trials Research Report on Oligospermia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Tolerability, Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Medicinal Product MediReg® Medicinal product MediReg® (Human Mesenchymal Stromal Cell Secretome), lyophilizate for preparation of solution for injection in patients with severe spermatogenesis disorders, Clostilbegit (clomiphene) 50 mg 1 tablet x 1 p a day - 3 months, Triovit - 1 tablet x 1 p a day - 3 months, Folic acid - 1 tablet x 1 p a day - 3 months. - Azoospermia, Nonobstructive, Teratospermia | Phase 1 / Phase 2 | Recruiting | Lomonosov Moscow State University Medical Research and Educational Center | 80 | 2024-11-26 | 2025-03-11 |
Azoospermia (1) · Azoospermia, Nonobstructive (1) · Teratozoospermia (1)
Genital Diseases (1) · Genital Diseases, Male (1) · Infertility (1) · Infertility, Male (1) · Male Urogenital Diseases (1) · Urogenital Diseases (1)
Clomiphene (1) · Injections (1)
Lomonosov Moscow State University Medical Research and Educational Center (1)
Russia (1)
Anastasia Efimenko, doctor of sciences (1) · Dmitry Okhobotov, doctor of sciences (1)